drugset / Trial / NCT03683914
Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the effectiveness of vaginal dinoprostone with placebo in minimising the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.
Timeline
- Start
- 2018-09-30
- Primary completion
- 2019-01-30
- Completion
- 2019-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 3 mg | Intravenous |
Indications
No indication recorded.